Oregon Joined Genomic Newborn Screening Research Study
Newborns in Oregon can now participate in a study testing for over 700 genetic conditions.
Updated on Oct. 12, 2026 in Babies
Live Poll
Should medical systems prioritize expanded genetic screening for newborns despite potential risks?
Oregon has joined the BRIDGES-NBS research study, which screens infants for more than 700 genetic conditions. This program offers expanded testing to families alongside the state's standard newborn screening protocols.
Why it matters
Standard screening programs have not kept pace with the rapid advancement of pediatric treatments. By identifying genetic markers earlier, this research aims to facilitate life-saving interventions within the first year of life.
The BRIDGES-NBS study evaluates the implementation of genomic technology to screen for over 700 conditions, a significant expansion over the 46 conditions currently detected in standard newborn screening programs.
The players
PeaceHealth Sacred Heart Medical Center RiverBend
A medical facility serving as a designated enrollment site for families participating in the BRIDGES-NBS genomic study.
OHSU
A research and clinical institution acting as an enrollment site for the statewide genomic screening research project.
The details
The program analyzes a blood sample from an infant to identify genetic abnormalities across a broad spectrum of conditions. By utilizing genomic sequencing, the study aims to provide earlier diagnostic data that current biochemical screening methods cannot detect. Families can enroll their newborns at designated medical sites or independently to participate in this expanded diagnostic evaluation.
Timeline
1963 marked the start of the regular newborn screening program.
Health Landscape
This program marks a departure from the standard newborn screening protocols established in 1963. It represents a shift toward integrating advanced genomic technology into early-life diagnostics to address the limitations of conventional screening methods.
Participation in the BRIDGES-NBS study is free and does not replace your baby's standard newborn screening. If you are interested in genomic testing, it is worth discussing the study's scope and implications with your pediatrician or obstetrician.
The takeaway
This genomic study represents a major advancement in the potential for early intervention in rare genetic disorders. Parents interested in these expanded insights should consult their healthcare provider to determine if participation is appropriate for their family.
Further reading
Learn more about the latest developments in early childhood health by visiting our Babies section.
Source note: This article includes information reported by Opb.
Live Poll
Should medical systems prioritize expanded genetic screening for newborns despite potential risks?
